Skip to main content
. 2018 Jun 21;37(9):1735–1744. doi: 10.1007/s10096-018-3306-7

Table 2.

The fraction of MRSA-positive individuals at each time point

Baseline 3 months 6 months 9 months 12 months
Placebo 33/33 (100%) 22/32 (69%) 23/33 (70%) 17/33 (52%) 21/33 (64%)
Vitamin D 32/32 (100%) 20/29 (69%) 18/28 (64%) 16/24 (67%) 13/25 (52%)
p value 1.00 1.00 0.79 0.24 0.43

The figures designate numbers of individuals being positive for MRSA, divided per total number of individuals with available information. The percentage is written out in parenthesis